| 1 |
Proteome Profiling of Human Cutaneous Leishmaniasis Lesion |
|
|
| Claire da Silva Santos,Sanaz Attarha,Ravi Kanth Saini,Viviane Boaventura,Jackson Costa,Ricardo Khouri,Manoel Barral-Netto,Cláudia Ida Brodskyn,Serhiy Souchelnytskyi |
|
| Journal of Investigative Dermatology. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis – an experimental study |
|
|
| Jyoti Joshi,Nancy Malla,Sukhbir Kaur |
|
| Parasitology International. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains |
|
|
| Dirlei Nico,Daniele Crespo Gomes,Marcus VinÃcius Alves-Silva,Elisangela Oliveira Freitas,Alexandre Morrot,Diana Bahia,Marcos Palatnik,Mauricio M. Rodrigues,Clarisa B. Palatnik-de-Sousa |
|
| Frontiers in Immunology. 2014; 5 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Identifying vaccine targets for anti-leishmanial vaccine development |
|
|
| Shyam Sundar,Bhawana Singh |
|
| Expert Review of Vaccines. 2014; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
FOXP3 expression and frequency of regulatory T cells in healed individuals from Leishmania major infection and the asymptomatic cases |
|
|
| Fariborz Bahrami,Haiedeh Darabi,Farhad Riazi-Rad,Vahid Khaze,Soheila Ajdary,Mohammad Hossein Alimohammadian |
|
| Human Immunology. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches |
|
|
| Sumit Joshi,Keerti Rawat,Narendra Kumar Yadav,Vikash Kumar,Mohammad Imran Siddiqi,Anuradha Dube |
|
| Frontiers in Immunology. 2014; 5 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Immune signal transduction in leishmaniasis from natural to artificial systems: Role of feedback loop insertion |
|
|
| Milsee Mol,Milind S. Patole,Shailza Singh |
|
| Biochimica et Biophysica Acta (BBA) - General Subjects. 2014; 1840(1): 71 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Exploring the Role of Medicinal Plant-Based Immunomodulators for Effective Therapy of Leishmaniasis |
|
|
| Garima Chouhan,Mohammad Islamuddin,Dinkar Sahal,Farhat Afrin |
|
| Frontiers in Immunology. 2014; 5 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms |
|
|
| Pedro A. Martinez,Christine A. Petersen |
|
| Immunologic Research. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis |
|
|
| Bhavana Sethu Lakshmi,Ruobing Wang,Rentala Madhubala |
|
| Vaccine. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases |
|
|
| Guillermo Arango Duque,Albert Descoteaux |
|
| Frontiers in Immunology. 2014; 5 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins |
|
|
| Maria Agallou,Evita Athanasiou,Olga Koutsoni,Eleni Dotsika,Evdokia Karagouni |
|
| Frontiers in Immunology. 2014; 5 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis |
|
|
| Toni Aebischer |
|
| Frontiers in Immunology. 2014; 5 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Isobenzofuranone derivatives exhibit antileishmanial effect by inhibiting type II DNA topoisomerase and inducing host response |
|
|
| Amartya Mishra,Jayaraman Vinayagam,Sourav Saha,Sayan Chowdhury,Somenath Roychowdhury,Parasuraman Jaisankar,Hemanta K. Majumder |
|
| Pharmacology Research & Perspectives. 2014; 2(6): n/a |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Cheminformatic models based on machine learning for pyruvate kinase inhibitors of Leishmania mexicana |
|
|
| Salma Jamal,Vinod Scaria |
|
| BMC Bioinformatics. 2013; 14(1): 329 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Interactions of antiparasitic alkaloids withLeishmaniaprotein targets: a molecular docking analysis |
|
|
| Ifedayo Victor Ogungbe,Joseph D Ng,William N Setzer |
|
| Future Medicinal Chemistry. 2013; 5(15): 1777 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Investigation of antileishmanial activities of [email protected] nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro |
|
|
| Adil M. Allahverdiyev,Emrah Sefik Abamor,Melahat Bagirova,Serap Yesilkir Baydar,Sezen Canim Ates,Figen Kaya,Cengiz Kaya,Miriam Rafailovich |
|
| Experimental Parasitology. 2013; 135(1): 55 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Vaccination model for visceral leishmaniasis with infective immigrants |
|
|
| Ibrahim M. ELmojtaba,J.Y.T. Mugisha,Mohsin H.A. Hashim |
|
| Mathematical Methods in the Applied Sciences. 2013; 36(2): 216 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends |
|
|
| Ali Badiee,Vahid Heravi Shargh,Ali Khamesipour,Mahmoud Reza Jaafari |
|
| Vaccine. 2013; 31(5): 735 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
TLR-mediated distinct IFN-?/IL-10 pattern induces protective immunity against murine visceral leishmaniasis |
|
|
| Joydeep Paul,Subir Karmakar,Tripti De |
|
| European Journal of Immunology. 2012; 42(8): 2087 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Leishmaniasis cutánea |
|
|
| Julián Díaz Sánchez,Sagrario Barrientos Serrano,Silvia Morell Mañas |
|
| FMC - Formación Médica Continuada en Atención Primaria. 2012; 19(3): 117 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection |
|
|
| Felix Hugentobler,Raphaël B. Di Roberto,Joshua Gillard,Benoit Cousineau |
|
| Vaccine. 2012; 30(39): 5726 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection |
|
|
| S.A. Campbell,J. Alawa,B. Doro,F.L. Henriquez,C.W. Roberts,A. Nok,C.B.I. Alawa,M. Alsaadi,A.B. Mullen,K.C. Carter |
|
| Vaccine. 2012; 30(7): 1357 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Characterization of Leishmania infantum thiol-dependent reductase 1 and evaluation of its potential to induce immune protection |
|
|
| A. M. SILVA,J. TAVARES,R. SILVESTRE,A. OUAISSI,G. H. COOMBS,A. CORDEIRO-da-SILVA |
|
| Parasite Immunology. 2012; 34(6): 345 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
Proteoliposomes in nanobiotechnology |
|
|
| P. Ciancaglini,A. M. S. Simão,M. Bolean,J. L. Millán,C. F. Rigos,J. S. Yoneda,M. C. Colhone,R. G. Stabeli |
|
| Biophysical Reviews. 2012; 4(1): 67 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
Innate Immunity and Leishmania Vaccination Strategies |
|
|
| Ron Birnbaum,Noah Craft |
|
| Dermatologic Clinics. 2011; 29(1): 89 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 27 |
Visceral leishmaniasis: immunology and prospects for a vaccine |
|
|
| P. M. Kaye,T. Aebischer |
|
| Clinical Microbiology and Infection. 2011; 17(10): 1462 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 28 |
Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium |
|
|
| Igor Grekov,Milena Svobodová,Eva Nohýnková,Marie Lipoldová |
|
| Journal of Microbiological Methods. 2011; 87(3): 273 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 29 |
Actualités sur les leishmanioses viscérales |
|
|
| B. Faucher,R. Piarroux |
|
| La Revue de Médecine Interne. 2011; 32(9): 544 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 30 |
Leishmaniasis: complexity at the host–pathogen interface |
|
|
| Paul Kaye,Phillip Scott |
|
| Nature Reviews Microbiology. 2011; 9(8): 604 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
